116 related articles for article (PubMed ID: 24021358)
41. Sequential treatment of oxaliplatin-containing PEGylated liposome together with S-1 improves intratumor distribution of subsequent doses of oxaliplatin-containing PEGylated liposome.
Nakamura H; Doi Y; Abu Lila AS; Nagao A; Ishida T; Kiwada H
Eur J Pharm Biopharm; 2014 May; 87(1):142-51. PubMed ID: 24361534
[TBL] [Abstract][Full Text] [Related]
42. Fluorescence-labeled liposome accumulation in injured colon of a mouse model of T-cell transfer-mediated inflammatory bowel disease.
Yamasaki M; Muraki Y; Nishimoto Y; Murakawa Y; Matsuo T
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):188-193. PubMed ID: 29037813
[TBL] [Abstract][Full Text] [Related]
43. Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions.
Heye T; Davenport MS; Horvath JJ; Feuerlein S; Breault SR; Bashir MR; Merkle EM; Boll DT
Radiology; 2013 Mar; 266(3):801-11. PubMed ID: 23220897
[TBL] [Abstract][Full Text] [Related]
44. Automated voxel-based analysis of volumetric dynamic contrast-enhanced CT data improves measurement of serial changes in tumor vascular biomarkers.
Coolens C; Driscoll B; Chung C; Shek T; Gorjizadeh A; Ménard C; Jaffray D
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):48-57. PubMed ID: 25446606
[TBL] [Abstract][Full Text] [Related]
45. Feasibility of Using Volumetric Contrast-Enhanced Ultrasound with a 3-D Transducer to Evaluate Therapeutic Response after Targeted Therapy in Rabbit Hepatic VX2 Carcinoma.
Kim J; Kim JH; Yoon SH; Choi WS; Kim YJ; Han JK; Choi BI
Ultrasound Med Biol; 2015 Dec; 41(12):3131-9. PubMed ID: 26365926
[TBL] [Abstract][Full Text] [Related]
46. Perfusion computed tomography could be a new tool for single-session imaging of ureteric obstructive pathology: an experimental study in rats.
Yilmaz O; Ovali GY; Genc A; Tarhan S; Ozcan T; Tuncyurek O; Pabuscu Y; Taneli C
J Pediatr Surg; 2009 Oct; 44(10):1977-83. PubMed ID: 19853758
[TBL] [Abstract][Full Text] [Related]
47. Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound.
Goetti R; Reiner CS; Knuth A; Klotz E; Stenner F; Samaras P; Alkadhi H
Invest Radiol; 2012 Jan; 47(1):18-24. PubMed ID: 21788906
[TBL] [Abstract][Full Text] [Related]
48. Rapid and continuous accumulation of nitric oxide-releasing liposomes in tumors to augment the enhanced permeability and retention (EPR) effect.
Yoshikawa T; Mori Y; Feng H; Phan KQ; Kishimura A; Kang JH; Mori T; Katayama Y
Int J Pharm; 2019 Jun; 565():481-487. PubMed ID: 31102802
[TBL] [Abstract][Full Text] [Related]
49. Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy.
Miyata S; Kawabata S; Hiramatsu R; Doi A; Ikeda N; Yamashita T; Kuroiwa T; Kasaoka S; Maruyama K; Miyatake S
Neurosurgery; 2011 May; 68(5):1380-7; discussion 1387. PubMed ID: 21273928
[TBL] [Abstract][Full Text] [Related]
50. Optimized time-resolved imaging of contrast kinetics (TRICKS) in dynamic contrast-enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models.
Haeck J; Bol K; Bison S; van Tiel S; Koelewijn S; de Jong M; Veenland J; Bernsen M
Contrast Media Mol Imaging; 2015; 10(6):413-20. PubMed ID: 25995102
[TBL] [Abstract][Full Text] [Related]
51. Use of avidin/biotin-liposome system for enhanced peritoneal drug delivery in an ovarian cancer model.
Zavaleta CL; Phillips WT; Soundararajan A; Goins BA
Int J Pharm; 2007 Jun; 337(1-2):316-28. PubMed ID: 17276633
[TBL] [Abstract][Full Text] [Related]
52. Dynamic contrast-enhanced magnetic resonance imaging of human cervical carcinoma xenografts: pharmacokinetic analysis and correlation to tumor histomorphology.
Ellingsen C; Egeland TA; Galappathi K; Rofstad EK
Radiother Oncol; 2010 Nov; 97(2):217-24. PubMed ID: 20656365
[TBL] [Abstract][Full Text] [Related]
53. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft.
Yuan F; Leunig M; Huang SK; Berk DA; Papahadjopoulos D; Jain RK
Cancer Res; 1994 Jul; 54(13):3352-6. PubMed ID: 8012948
[TBL] [Abstract][Full Text] [Related]
54. APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomes.
Dunne M; Zheng J; Rosenblat J; Jaffray DA; Allen C
J Control Release; 2011 Sep; 154(3):298-305. PubMed ID: 21640146
[TBL] [Abstract][Full Text] [Related]
55. Investigation of Factors Determining the Enhanced Permeability and Retention Effect in Subcutaneous Xenografts.
Bolkestein M; de Blois E; Koelewijn SJ; Eggermont AM; Grosveld F; de Jong M; Koning GA
J Nucl Med; 2016 Apr; 57(4):601-7. PubMed ID: 26719375
[TBL] [Abstract][Full Text] [Related]
56. Nanoliposome-mediated targeting of antibodies to tumors: IVIG antibodies as a model.
Nikpoor AR; Tavakkol-Afshari J; Gholizadeh Z; Sadri K; Babaei MH; Chamani J; Badiee A; Jalali SA; Jaafari MR
Int J Pharm; 2015 Nov; 495(1):162-170. PubMed ID: 26302860
[TBL] [Abstract][Full Text] [Related]
57. Dynamic contrast-enhanced MRI and CT provide comparable measurement of blood-brain barrier permeability in a rodent stroke model.
Merali Z; Wong T; Leung J; Gao MM; Mikulis D; Kassner A
Magn Reson Imaging; 2015 Oct; 33(8):1007-12. PubMed ID: 26117703
[TBL] [Abstract][Full Text] [Related]
58. A comparison of tracer kinetic models for T1-weighted dynamic contrast-enhanced MRI: application in carcinoma of the cervix.
Donaldson SB; West CM; Davidson SE; Carrington BM; Hutchison G; Jones AP; Sourbron SP; Buckley DL
Magn Reson Med; 2010 Mar; 63(3):691-700. PubMed ID: 20187179
[TBL] [Abstract][Full Text] [Related]
59. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.
Hawighorst H; Knapstein PG; Knopp MV; Weikel W; Brix G; Zuna I; Schönberg SO; Essig M; Vaupel P; van Kaick G
Cancer Res; 1998 Aug; 58(16):3598-602. PubMed ID: 9721867
[TBL] [Abstract][Full Text] [Related]
60. Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.
Fruytier AC; Magat J; Neveu MA; Karroum O; Bouzin C; Feron O; Jordan B; Cron GO; Gallez B
NMR Biomed; 2014 Nov; 27(11):1403-12. PubMed ID: 25323069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
